EUVIMEDEUVIMED entdecken
Crossref

Oncolytic Virus Targeted Therapy for Glioma via Intravenous Delivery

Yechenxing He, Wei Li, Xiaowei Zhang, Zongqiang Cui iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202404965 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Yechenxing He und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, P. R. C…. Hauptthemen laut MEDLINE: Glioma, Oncolytic Virotherapy, Oncolytic Viruses, Brain Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation, National Key Research and Development Program, R&D Program of Guangzhou National Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioma, the deadly primary intracranial tumor, poses challenges in clinical treatment due to its infiltrative growth and resistance to radiation. Oncolytic virus therapy holds potential for the treatment of malignant gliomas, but its application is impeded by the requirement for intracranial injections due to the presence of blood‐brain barrier (BBB). In this study, to overcome this limitation, the study develops a nanocapsule encapsulating the recombinant oncolytic virus EV‐A71‐miR124T, enabling the treatment of glioma through intravenous administration. It is demonstrated that the nanocapsule can cross the BBB and selectively release oncolytic virus at the tumor site, resulting in targeted and specific killing of glioma cells. In mice with implanted intracranial orthotopic gliomas, intravenous administration of the nanocapsule suppresses tumor growth and significantly extends survival time. Consequently, the study establishes an effective treatment method for malignant gliomas using an oncolytic virus nanocapsule through intravenous administration. These findings provide a new strategy for oncolytic virus therapy in glioma treatment and offer perspectives for targeted therapies of other brain tumors and diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaOncolytic VirotherapyOncolytic VirusesBrain NeoplasmsNanocapsulesAnimalsCell Line, TumorMiceHumansBlood-Brain BarrierAdministration, IntravenousMice, Nude

Stichwörter der Autor:innen

blood–brain barriergliomaintravenous deliverynanocapsuleoncolytic virus

Substanzen

Nanocapsules

Autor:innen und Institutionen

  • State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, P. R. China.
  • University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.

ORCID-Profile: Zongqiang Cui

Förderung

  • National Natural Science Foundation
  • National Key Research and Development Program
  • R&D Program of Guangzhou National Laboratory
  • National Key Research and Development Program of China

Zitieren

APA

He, Y., Li, W., Zhang, X., & Cui, Z. (2025). Oncolytic Virus Targeted Therapy for Glioma via Intravenous Delivery. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202404965

Vancouver

He Y, Li W, Zhang X, Cui Z. Oncolytic Virus Targeted Therapy for Glioma via Intravenous Delivery. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202404965

BibTeX
@article{He2025,
  author = {He, Yechenxing and Li, Wei and Zhang, Xiaowei and Cui, Zongqiang},
  title = {Oncolytic Virus Targeted Therapy for Glioma via Intravenous Delivery},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202404965}
}
Kostenlos starten →